In tumor models, neutrophils can be converted from anti-tumor phenotype (N1: release ROS and TNF-α) to pro-tumor phenotype (N2: increased Arginase, CCL2, and CCL5) by the TGF-β stimulation [194]. The gene discussed is CCL2; the disease is neoplasm.